Search
forResearch 10 of 1000+
- LB793 A phase 1, open-Label, single ascending dose study in healthy subjects of the safety, tolerability and pharmacokinetics of ASLAN004, a novel IgG anti-IL-13 receptor alpha 1 Inhibitor
- A Potential Role for IL-4 and IL-13 in an Alopecia Areata–Like Phenotype: A Clinical Perspective
- Single‐cell transcriptomics reveals a senescence‐associated IL ‐6/ CCR6 axis driving radiodermatitis
- Increased Macrophage Migration Inhibitory Factor (MIF) in the Sera of Patients with Extensive Alopecia Areata
- Treatment of Cultured Sebocytes with an EGFR Inhibitor Does Not Lead to Significant Upregulation of Inflammatory Biomarkers
- Off-label use of biologics and janus kinase (JAK) inhibitors for scarring alopecias: a narrative review
- Interleukin-1β Is Differentially Expressed by Human Dermal Papilla Cells in Response to PKC Activation and Is a Potent Inhibitor of Human Hair Follicle Growth in Organ Culture
- Tralokinumab as a therapeutic option for patients with concurrent atopic dermatitis and alopecia areata
- Biologics in the management of childhood atopic dermatitis
- Alopecia Areata and Atopic Dermatitis: Common Mechanisms and Emerging Therapeutics
Learn
— no results
Try a deeper search in learn →Community
— no results
Try a deeper search in community →